WEEKLY NANOPARTICLE ALBUMIN-BOUND PACLITAXEL (ABRAXANE) + WEEKLY CETUXIMAB + RADIATION THERAPY (IMRT, INTENSITY-MODULATED RADIATION THERAPY) IN PATIENTS WITH STAGE III-IVB HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC):